In:
Der Nervenarzt, Springer Science and Business Media LLC, Vol. 94, No. 8 ( 2023-08), p. 725-733
Abstract:
Over the past 5 years both media and scientific interest has surged regarding the disorder myalgic encephalomyelitis and chronic fatigue syndrome (ME/CFS), not least because of the clinically similar manifestation in long COVID or post-COVID. In this review we discuss the process of clinical diagnosis and randomized controlled therapeutic studies on ME/CFS, and the similarities or differences to long COVID and post-COVID. So far, neither clear pathophysiologically causal nor therapeutic evidence-based results on ME/CFS have been identified in the many years of scientific research. Given the evident psychiatric comorbidity rates in patients with a diagnosis of ME/CFS, a psychosomatic etiology of this syndrome should be considered. Furthermore, a precise and reliable diagnostic classification based on stricter criteria would benefit both pathophysiological and therapeutic research.
Type of Medium:
Online Resource
ISSN:
0028-2804
,
1433-0407
DOI:
10.1007/s00115-022-01431-x
Language:
German
Publisher:
Springer Science and Business Media LLC
Publication Date:
2023
detail.hit.zdb_id:
1462945-8
detail.hit.zdb_id:
123291-5
SSG:
2,1